Cynthia Guzzo

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Craig L. Leonardi, Alexa B. Kimball, Kim Papp et al. · The Lancet · 2008 · 1.9K citations

76-Week Results, Immunology, Clinical Trials +7

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Kim Papp, Richard G. Langley, Mark Lebwohl et al. · The Lancet · 2008 · 1.3K citations

Immunology, Clinical Trials, Clinical Dermatology +7

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

William J. Sandborn, Christopher Gasink, Long-Long Gao et al. · New England Journal of Medicine · 2012 · 1.1K citations

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Kristian Reich, Frank O. Nestlé, Kim Papp et al. · The Lancet · 2005 · 1K citations

Infliximab Induction, Systemic Treatment, Phase Iii +7

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

William J. Sandborn, Brian G. Feagan, Colleen Marano et al. · Gastroenterology · 2013 · 912 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Autoimmune Disease +6